Examining FeNO and CRP levels helps clinicians understand the intricate interplay between asthma and sleep apnea, making asthma more manageable, reducing exacerbations, and minimizing the impact of sleep apnea on patients. The gene discussed is CRP; the disease is sleep apnea syndrome.